VANCOUVER, BC – (GLOBE NEWSWIRE) – June 3, 2021 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce patients will soon have access to its innovative point-of-care blood screening and health-data management platform, HealthTab™, at select Shoppers Drug Mart locations. Through this pilot program, patients will have greater

VANCOUVER, BC – (GLOBE NEWSWIRE) – May 31, 2021 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a supplier distribution agreement between HealthTab™ Inc., a wholly owned subsidiary, and Abbott, the global healthcare company and diagnostics leader, in Canada. This agreement allows the Company

The Company welcomes the return of Will Seccombe, co-creator of HealthTab™, as he takes on the Company’s communications strategies to support the next growth phase. VANCOUVER, BC  – March 26, 2021 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) Avricore Health is pleased to announce the

Utilizing HealthTab™ and rapid-antigen tests at resort locations to screen for the virus prior to return, with validation from Avrok Laboratories, US travellers can return home with peace of mind.  VANCOUVER, BC – (GLOBE NEWSWIRE) – February 16, 2021 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce

VANCOUVER, BRITISH COLUMBIA – February 9, 2021 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) announces it has closed its non-brokered private placement announced on February 3rd for gross proceeds of $1,540,000. The Company will issue 7,000,000 units at $0.22 per unit and will pay finders fees totaling

VANCOUVER, BC – (GLOBE NEWSWIRE) – February 9, 2021 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce it will be placing its real-time reporting HealthTabÔ systems in Whole Health Pharmacy Partner locations. “We’ve been excited by the amount of interest and support building for HealthTab™,” said Avricore

VANCOUVER, BRITISH COLUMBIA – February 3, 2021 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) announces a non-brokered private placement of up to 7,000,000 units (“Units“) at a price of $0.22 per unit for gross proceeds of $1,540,000. (the “Private Placement“). The proceeds will be used for general

VANCOUVER, BRITISH COLUMBIA – January 26, 2021 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) announces it has closed the final tranche of its non-brokered private placement for gross proceeds of $874,000 to complete its $1.5 million financing. The Company will issue 8,740,000 units at $0.10 per unit

Earlier this fall, the Company announced a joint working agreement to integrate a major manufacturer’s devices with its HealthTab™ data reporting platform for deployment in Canada, resulting in new testing capabilities, including COVID-19 molecular PCR results via the ID Now™.  VANCOUVER, BRITISH COLUMBIA – December 14, 2020 – AVRICORE HEALTH

The Company welcomes CTO Rodger Seccombe, co-creator of HealthTab to the Board. Thanks, Bobby Rai for his service and leadership on the Board of Directors and as President he takes advisory role. VANCOUVER, BC – December 10th, 2020 – Avricore Health Inc.(TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) announces changes